Previous 10 | Next 10 |
Twist Bioscience (NASDAQ: TWST ) : Q3 GAAP EPS of -$0.67 beats by $0.15 . More news on: Twist Bioscience Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
– Strong Third Quarter Fiscal 2020 Revenues of $21.2M; Increase of 56% over Third Quarter Fiscal 2019 – Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today ...
Twist Bioscience ( TWST +1.3% ) inks an agreement with privately held Seismic Bio aimed at the discovery and optimization of antibodies to "high value" immuno-oncology (I-O) targets. More news on: Twist Bioscience Corporation, Healthcare stocks news, Stocks on the move, Read more ....
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Seismic Bio, Inc., an immuno-oncology company focused on bispecific antibody development, today announced a partnership for t...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2020 third quarter ended June 30, 2020, following the clo...
Twist Bioscience (NASDAQ: TWST ) has announced the availability of two new SARS-CoV-2 antibody panels designed for research use only. More news on: Twist Bioscience Corporation, Healthcare stocks news, Read more ...
-- Panel 1 Targets SARS-CoV-2 Spike Protein; Panel 2 Targets Human ACE2 -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of two new SAR...
Twist Bioscience (NASDAQ: TWST ) announces the addition of 16 new synthetic controls for environmental testing, assay development, verification, and ongoing validation of diagnostic tests for a broad range of common respiratory diseases. More news on: Twist Bioscience Corporation, Heal...
Increasing losses, additional stock dilution, and a lack of financial details in newly announced collaborations have proven no deterrent to the upward trajectory of Twist Bioscience (NASDAQ: TWST) stock. Shares of the DNA synthesis company have soared 186% since the beginning of 2020. Due to...
-- Includes SARS-CoV-2 Synthetic RNA Control with D614G Mutation -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of its infectious diseas...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...